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Dystrophin and Dystroglycan are the two central components of the multimeric Dystrophin Associated Protein Complex, or DAPC, that is
thought to provide a mechanical link between the extracellular matrix and the actin cytoskeleton, disruption of which leads to muscular dystrophy
in humans. We present the characterization of the Drosophila ‘crossveinless’ mutation detached (det), and show that the gene encodes the fly
ortholog of Dystrophin. Our genetic analysis shows that, in flies, Dystrophin is a non-essential gene, and the sole overt morphological defect
associated with null mutations in the locus is the variable loss of the posterior crossvein that has been described for alleles of det. Null mutations in
Drosophila Dystroglycan (Dg) are similarly viable and exhibit this crossvein defect, indicating that both of the central DAPC components have
been co-opted for this atypical function of the complex. In the developing wing, the Drosophila DAPC affects the intercellular signalling
pathways involved in vein specification. In det and Dg mutant wings, the early BMP signalling that initiates crossvein specification is not
maintained, particularly in the pro-vein territories adjacent to the longitudinal veins, and this results in the production of a crossvein fragment in
the intervein between the two longitudinal veins. Genetic interaction studies suggest that the DAPC may exert this effect indirectly by down-
regulating Notch signalling in pro-vein territories, leading to enhanced BMP signalling in the intervein by diffusion of BMP ligands from the
longitudinal veins.
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Studies on the patterning and morphogenesis of the veins in
the Drosophila wing have shown this process to be an ideal
system for studying interactions between intercellular signalling
pathways in development. To date, four different signalling
pathways have been implicated in the process: the Epidermal
Growth Factor Receptor (EGFR) pathway, the Bone Morpho-
genetic Protein (BMP) pathway, the Notch pathway, and, more
recently, a pathway involving Rho GTPases (Denholm et al.,
2005). These different pathways interact and feed back on one⁎ Corresponding author. Fax: +44 1273 687433.
E-mail address: r.ray@sussex.ac.uk (R.P. Ray).
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doi:10.1016/j.ydbio.2007.09.044another, initially to define vein and intervein territories in the
wing imaginal disc, and later to regulate and refine the vein
pattern as the wing undergoes differentiation during pupal
development (reviewed in Bier, 2000; Crozatier et al., 2004; de
Celis, 2003).
The Drosophila wing is characterized by a stereotypical
pattern of five longitudinal veins (L1–L5) and two crossveins,
the anterior crossvein (acv) and the posterior crossvein (pcv)
(Fig. 1A). The pattern of longitudinal veins is laid down in the
late third instar with respect to territories that are defined by the
morphogens Decapentaplegic (Dpp) and Hedgehog (Crozatier
et al., 2004; de Celis, 2003). This pattern is first evidenced by
the localized expression of rhomboid (rho), a protease required
for activation of EGFR ligands (Urban et al., 2002), in a series
of stripes corresponding to each of the longitudinal veinsc. All rights reserved.
Fig. 1. Wing phenotypes produced by detachedmutations. (A) Awild type wing
showing the positions of the two crossveins, the anterior crossvein (acv)
between longitudinal veins L3 and L4, and the posterior crossvein (pcv) between
longitudinal veins L4 and L5. The region of the wing shown in panels B to G is
boxed. Representative pcv defects observed in flies homozygous for det1. In
these flies, the vein may be: “complete” (CO), (B); gapped (GP), either from L4
as an anterior gap (C); or from L5 as a posterior gap (D); “detached” (DE), (E);
“point” (PT), (F); or “crossveinless” (CV), (G). In all det mutations we have
studied, the acv is not consistently affected, so we have not considered it in this
report.
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these cells results in an initial “ON–OFF” pattern of vein and
intervein cells, the former expressing rho and the Notch ligand
Delta, and the latter expressing the Drosophila ortholog of the
Serum Response Factor, or Blistered (Bs), and Notch itself (de
Celis et al., 1997; Montagne et al., 1996). The establishment of
these expression patterns initiates the basic regulatory loop that
governs vein development, with rho-dependent EGFR signal-
ling activating expression of Delta and repressing expression of
Bs and Notch, and, in return, both Notch signalling and Bs
repressing the activity of the EGFR pathway and the expression
of rho.This basic signalling network is elaborated during pupal
development at the time of the final apposition of dorsal and
ventral wing surfaces. At this stage, the wing blade is
subdivided into the so-called ‘vein’, ‘pro-vein’, and ‘intervein’
territories. rho expression prefigures the longitudinal vein
pattern and is expressed in all vein territories, Delta is
expressed in a broader domain including both vein and pro-
vein territories, Notch is expressed in pro-vein and intervein
territories and up-regulated in pro-vein cells, and Bs is
expressed uniformly in pro-vein and intervein cells (see Fig.
8A; Sotillos and De Celis, 2005). Notch activity, as evidenced
by the expression of the Notch target gene Enhancer of split
(E(spl)), is confined to the pro-veins (de Celis, 1997).
Expression of the BMP ligand dpp is first detectable in vein
cells at this time, and overlaps the rho pattern, while its
receptor, thickveins (tkv), is expressed in a pattern similar to
Notch (de Celis, 1997). The BMP and EGFR signalling
systems form a positive feedback loop, with expression of rho
depending on the activity of dpp and vice versa (de Celis,
1997), and both systems are independently repressed by the
activity of the Notch pathway in pro-vein cells (de Celis et al.,
1997). In the case of rho, Notch signalling results in repression
of rho and down-regulation of EGFR activity, and for dpp,
Notch signalling up-regulates tkv, which limits Dpp diffusion
and confines BMP signalling to the vein territory (Fig. 8A; de
Celis, 1997; de Celis et al., 1997).
Crossvein specification begins after the two surfaces of the
wing have apposed, and after the regulatory network involving
EGFR, Notch, and BMP signalling has been established in the
longitudinal veins. In this regard, the crossvein pattern is
superimposed on the pre-existing pattern of longitudinal veins.
This process is initiated by BMP signalling, as evidenced by
early expression of the phosphorylated form of the BMP signal
transducer Mothers Against Dpp (P-Mad), which first appears
in broad domains at the sites of the presumptive acv and pcv,
and then sharpens until the crossveins resemble the long-
itudinal veins (Conley et al., 2000). Two BMP ligands are
required for crossvein development, Dpp and the BMP5,6,7,8
ortholog Gbb (Ray and Wharton, 2001). The early broad
expression of P-Mad is dependent on Gbb and precedes the
localized expression of dpp that first appears once the
crossvein domains have refined (Ralston and Blair, 2005).
Expression of dpp is coincident with the expression of rho and
Delta, and once all three genes are expressed, the regulatory
circuit operating in the longitudinal veins is recapitulated in the
crossveins.
Crossvein specification appears to be quite sensitive to
perturbations in BMP signalling, and a number of ‘cross-
veinless’ genes, including the BMP-1 ortholog tolkin, cross-
veinless (cv), and crossveinless-2 (cv-2) have been shown to be
components of the BMP signalling pathway (Finelli et al., 1995,
Conley et al., 2000; Shimmi et al., 2005; Vilmos et al., 2005).
The recent characterization of crossveinless-c (cv-c) proved to
be an exception as it was shown to encode a RhoGAP, thus
implicating a different signalling pathway in the mechanism of
crossvein specification (Denholm et al., 2005). Notably, the
crossvein defect associated with cv-c is weaker than that of the
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only variably affected and, in most cases, a small fragment of
the pcv remains in the intervein between L4 and L5 (Denholm et
al., 2005). In this regard, cv-c does not appear to be essential for
crossvein development in the way that the BMP components
are, and thus may act to modulate the activity of the central
signalling components in crossvein specification.
In this report, we present genetic and molecular character-
ization of the ‘crossveinless’ gene, detached (det), which is
similar in phenotype to cv-c in that the crossveins, while
disrupted, are not completely absent. Genetic and molecular
characterization of det shows it to encode the Drosophila
ortholog of human Dystrophin, the gene that is associated with
the Becker and Duchenne Muscular Dystrophies in humans,
and one of the central components of the Dystrophin
Associated Protein Complex (DAPC) (reviewed in Blake et
al., 2002). Flies completely lacking Dystrophin are adult viable
and the crossvein defect is the sole overt morphological defect
seen in these animals. We show that mutations in the Droso-
phila ortholog of Dystroglycan, another central component of
the DAPC, also show the same crossvein defect as det
mutations. Both det and Dg are required for maintenance of
early BMP signalling in the presumptive crossvein, and
consistent with a link to the extracellular matrix, we show
that the initial stages of crossvein specification are accom-
panied by an accumulation of haemocytes in the presumptive
crossvein region that is dependent on both BMP and DAPC
function. Interaction studies suggest that the effect of det and
Dg on BMP signalling may not be direct but rather through
down-regulation of Notch signalling in the L4 and L5 pro-
veins which opens up the pcv territory to BMP ligands
diffusing from the longitudinal veins.
Materials and methods
Drosophila culture
Flies were cultured on standard yeast corn meal glucose medium at 25 °C.
The detached and Dystroglycan alleles, det1, det3397, Dg2241, deficiencies
Df(2R)ED2457, Df(3R)Exel6184, and Df(3R)ED5942, and the deficiency
lines used to map det were obtained from Bloomington and Szeged stock
centres. The dpp shortvein reporter construct RD2-lacZ was obtained from
D. Hursh and recombined onto the Df(3R)Exel6184 chromosome.Table 1
Relative viability of det and Dg alleles as hemizygotes
Cross a N
a/b a/B
det3397/TM6b×Df-6184/TM6b 771 382 –
det3397/Sb x Df-6184/TM6b 494 145 110
Df-6184/+ x Df-6184/+ 3780 468 –
DgO38/CyO x Df-2457/SM6a 293 71 105
DgO43/CyO x Df-2457/SM6a 440 105 150
DgO55/CyO x Df-2457/SM6a 451 111 150
DgO86/CyO x Df-2457/SM6a 989 275 397
a Alleles of det and Dg are as described in the text. Df-6184 is Df(3R)Exel6184, D
b Progeny classes are defined for the canonical cross of a/A×b/B referring to the g
the number of progeny is shown between the two columns.
c Percent of expected calculated by the formula: % Exp=100[(a/b)/((a/B+b/A)/2)Meiotic mapping of det1
det1males were crossed to st e virgin females, and det1/st e virgin F1 females
were collected and crossed to males carrying the balancer TM3, Sb.
Recombinant chromosomes were recovered in the F2 males in trans to TM3,
Sb. 114 of these were crossed singly to virgin females carrying a det allele
marked with st and e, and the F3 progeny scored for st, e and det. Results from
these experiments place the det locus 3 cM to the left of ebony (70.7 cM).
Out-crossing and Reversion of EP(3)3397
To remove lethal mutations from the EP(3)3397 chromosome, flies were
out-crossed to an isogenic y w1118 strain from which y w1118/w⁎EP(3)3397/+
females were recovered and back-crossed to y w1118males. This was repeated for
several generations, using the w+ marker on the transposon to follow the
insertion, after which individual EP(3)3397 chromosomes were recovered over
the balancer TM6b. To mobilize the insertion, a viable y w1118; det3397 line was
crossed to Δ2–3 Sb, and F1 males were crossed singly to w
1118; Df(3R)6184/
TM6b, Hu Tb females in vials. From each vial, a single white-eyed “revertant”
male carrying the balancer TM6b was crossed to w1118; Df(3R)Exel6184/TM6b,
Hu Tb females. From this cross, a stock was established over TM6b and the
phenotype of the revertant over Df(3R)Exel6184 determined.
Generation of flies homozygous for Df(3R)Exel6184
The appearance of rare homozygous escapers from the stock w1118;
Df(3R)Exel6184/TM3, P{ActGFP} Ser prompted us to outcross the deficiency
in order to make a homozygous stock. To this end, w1118; Df(3R)Exel6184/
TM6b, Hu Tb males were crossed to y w1118 females, heterozygous y w1118/
w1118; Df(3R)Exel6184/+ virgin females were collected and back-crossed to
y w1118 males. By virtue of the w+ marker that was generated by the
construction of the deficiency, a y w1118; Df(3R)Exel6184[w+]/+ ‘stock’ was
established from this cross and the progeny classes and flies were scored over
five generations to obtain the data in Table 1. The selected stock stably
maintains a viability of between 40% and 50%.
Generation and molecular characterization of Dystroglycan (Dg)
alleles
To isolate new alleles of Dg, the P-element insertion EP(2)2241 was
mobilized to generate imprecise excisions that delete the 5′ end of the gene. One
such excision, J43, was identified that was homozygous lethal, failed to
complement the adjacent gene CG8414, and carried a deletion extending into the
first large intron of Dg. This revertant was used as a tester chromosome for a
F1/F2 mutagenesis. Isogenic pr cn males were mutagenized with 30 mM Ethyl
methanesulfonate (EMS) and mated to J43/CyO females. The pr cn∗/J43
F1 males were scored for crossvein defects, while their pr cn∗/CyO siblings were
backcrossed singly to J43/CyO females and the F2 progeny scored for lethality
of the pr cn∗/J43 class. 35,000 chromosomes were scored in the F1 screen and 4Progeny classes b Percent
expected c
b/A A/B
389 – Lethal 196
145 94 100






enotypes in the first column. In cases where the classes cannot be distinguished,
].
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were scored in the F2 screen, and 2 mutants were recovered, OO7 and OO9, both
of which are alleles of CG8414. A series of overlapping primers were generated
that cover the coding sequences of all Dg transcripts, and these primers were
used to amplify fragments of Dg from flies hemizygous for each of the four
alleles, and then to sequence the fragments to determine the lesions. The
endpoints of the deletions in DgO38 and DgO55 were verified by sequencing on
both forward and reverse strands while the point mutations in DgO43 and DgO86
were confirmed by multiple sequences derived from independent PCR reactions.
The described mutations were the only unique changes associated with each
mutant sequence. A number of changes were identified which were common to
all four mutant sequences and thus polymorphisms between the genome
sequence and our isogenic pr cn line.
Interactions between det and BMP signalling components
For interactions between det and BMP signalling components on the second
chromosome, w; If/CyO,Δ2–3; MKRS/TM6b females were crossed separately to
BMP∗/Balancer males and homozygous det1 males. w/Y; BMP∗/CyO,Δ2–3;
MRKS/+ males from the former cross were mated with w/+; +/If; det1/TM6b
females from the latter, and F3 w/Y; BMP∗/If; det1/MKRS males were crossed
with w; Df(3R)Exel6184/TM6b females. The penetrance and expressivity of the
w; BMP∗/+; det1/Df(3R)Exel6184 progeny from this cross were compared with
that of their w; If/+; det1/Df(3R)Exel6184 siblings. BMP alleles used in these
studies were dpps4, dppd12, gbb1, tkv5, and Mad12. For Medea (Med), which lies
on the third chromosome, a recombinant was made between det1 andMed4, and
this was crossed directly to w; Df(3R)Exel6184/TM6b and the expressivity and
penetrance of the det1 Med4/Df(3R)Exel6184 progeny were compared to a
control cross using the parental det1 chromosome.
Polymerase Chain Reaction (PCR) and sequencing
For all reactions, a single fly was crushed with a pipet tip in 50 μl of buffer
(10 mM Tris–Cl pH 8.2; 1 mM EDTA pH 8.0; 25 mM NaCl). Proteinase K
(Roche) was added to a concentration of 200 μg/ml and the tube incubated at
37 °C for 30 min. The Proteinase K was inactivated by incubating the sample at
95 °c for 2 min, and the preparation centrifuged for 5 min at 13,000 rpm. PCR
was carried out using 1 μl of template, 0.5 Units Taq Polymerase (Eppendorf)
1.25 mM MgCl2, 200 μM of each dNTP, and 0.5 μM of each primer in a total
volume of 25 μl, using an Eppendorf Mastercycler ep Gradient Thermocycler. If
the product was to be sequenced, the amplified fragment was purified over a
QIAquick PCR purification column (Qiagen). Sequencing was performed by
MWG Biotech.
Immunohistochemistry
For antibody staining of pupal wings, white prepupae were selected and
aged as appropriate, then dissected in PBTx (1× PBS+0.3% Triton). Pupae were
fixed in 4% Formaldehyde (TAAB) in PBTx overnight at 4 °C. Fixed
preparations were rinsed 3×5 min in PBTx, the pupal cuticle was dissected
away, and the wings incubated for 1 h in Blocking Solution (PBTx+2% Normal
Goat Serum+0.1% BSA). Primary antibody was diluted in blocking solution (α-
pMad (C-H. Heldin) 1:3000; α-DSRF (Active Motif) 1:1000) and the wings
incubated with the antibody overnight at 4 °C. The samples were washed
3×20 min in PBTx+0.1% BSA. Secondary antibody was diluted in blocking
solution (1:1000 dilution of Goat-α-Rabbit-AlexaFluor-546 for P-Mad, Goat-α-
Mouse-Alexa-Fluor-488 for Bs, Molecular Probes) and the samples incubated
for 2 h at room temperature. Preparations were washed 3×15 min PBTx+0.1%
BSA, mounted in Aquapolymount (Polysciences), and imaged on a Zeiss
MetaCombi confocal microscope.
Staining for β-galactosidase activity
For detection of bacterial lacZ transgenes, white prepupae were selected and
aged, dissected in PBTx and fixed in 4% Formaldehyde overnight at 4 °C. The
carcasses were then washed 3×5 min in PBTx, and then put into Staining
solution (5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6, pH 7.0) for 10 min. X-gal(Melford) was added to a final concentration of 0.8 μg/ml and the samples
incubated for 4 h at 37 °C. The carcasses were washed 3×5 min in PBTx, fixed
for a final 10 min in 4% Formaldehyde in PBTx, and rinsed again 3×5 min in
PBTx. Wings were dissected from the carcasses and mounted in Aquapoly-
mount. Wings aged 70 h were expanded in 1 N NaOH at 37 °C for 1–2 h prior to
mounting. For detection of the endogenous β-galactosidase in haemocytes, the
protocol was the same except that the Staining solution used was at pH 6.0 and
the carcasses were stained overnight at 37 °C.
Results
The phenotype of detached
The detached (det) locus was originally described based on a
single spontaneous recessive viable allele, det1, which was
isolated by Nichols-Skoog in 1935, and mapped to 72.5 cM on
the right arm of chromosome 3. The phenotype of this mutation
was described as a variable defect in the formation of the
posterior crossvein, which may be detached from either L4 or
L5, detached from both, or in some cases absent (Lindsley and
Zimm, 1992). The latter phenotype puts det in the class of
“crossveinless” loci, a number of which have been implicated in
BMP signalling (O'Connor et al., 2006), but the milder defects
associated with the locus, implied by the name ‘detached’,
suggested that either the original allele is hypomorphic, or that
the locus is not essential for specification of the crossvein.
To quantify the det1 phenotype, five robust phenotypic
classes were defined to describe the variable expressivity of the
locus: “complete” in which the crossvein appears to be wild
type, “gapped” in which the crossvein is detached from either
L4 or L5 but not both, “detached” in which the crossvein is
detached from both L4 and L5, “point” in which the crossvein is
reduced to a point, and “crossveinless” in which the crossvein is
absent (Fig. 1). det1 homozygotes show incomplete penetrance
and variable expressivity, with 78% of the mutant individuals
having at least one wing with a defective crossvein, and 39%,
42%, 18% and 1% of the wings in classes “complete”, “gap”,
“detached”, and “point”, respectively (Fig. 2B).
To determine the genetic nature of the det1mutation, and also
to locate the gene, we sought to identify a deficiency that
uncovers the locus. The published map position of 72.5 cM
placed det in cytological subdivision 95, just distal to ebony
(70.7 cM), however, all deficiencies covering this region were
found to complement det. Given the absence of an obvious gap
in the deficiency series, the det1 allele was mapped by recom-
bination, and, contrary to the published data, it mapped 3 cM
proximal to ebony, placing the locus in subdivision 92. A single
deficiency in this region,Df(3R)Exel6184, failed to complement
det1 (Fig. 2A). A larger deficiency, Df(3R)ED5492, that spans
the region uncovered by Df(3R)Exel6184, appeared to comple-
ment det1, however, as we show below, this ‘complementation’
is due to suppression of the det phenotype by another gene
uncovered by the deficiency (see below).
Comparison of the phenotypes of det1 homozygotes and
hemizygotes shows that the phenotype is more severe when the
allele is in trans to the deficiency. The penetrance increases to
100%, and, while the range of phenotypes does not change, the
proportions in each class shift towards the “detached” class with
Fig. 2. The detached locus and expressivity of det alleles. (A) Top panel shows
the genetic map of chromosome 3R with the centromere as an open circle. While
det was originally mapped to 72.5 cM, placing the locus distal to ebony (e), our
mapping placed the gene at ∼67 cM, between Delta (Dl) and e in division 92A.
Middle panel shows the genomic interval from 91F–92B. Due to the scale of the
diagram, only major genes (N10 kb) in the interval are shown as narrow black
bars (Delta and detached are shown in red), and the tick lines on the scale bar
represent 100 kb. The extent of Df(3R)ED5942 and Df(3R)Exel6184 are shown
as hatched boxes above. Lower panel shows the most 5′ exons of the det
(Dystrophin) and the transcriptional start sites, DLP1, DLP2 and DLP3, for the
three long forms of the protein. Exons are shown as black boxes, and the tick
marks on the scale bar represent 5 kb. The insertion site of the P-element
EP(3)3397 is shown in the first intron of the DLP2 transcript, which corresponds to
the RA/C/F transcripts of Flybase. (B) Graphs showing the expressivity of de-
tached alleles on a per wing basis. Genotypes are shown in the upper right hand
corner of the graph beneath which the number of wings scored for that particular
genotype is indicated. “3397” refers to the P-element insertion EP(3)3397, and
“Df” refers to Df(3R)Exel6184, as described in the text. Abbreviations for
phenotypic classes on the horizontal axis are as defined in the legend to Fig. 1.
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“detached”, respectively (Fig. 2B). Thus, by this genetic
criterion, det1 behaves as a hypomorphic allele.
Detached encodes Drosophila Dystrophin
The deficiency that uncovers det spans 177 kb that includes
11 predicted genes (FlyBase). 133 kb of this interval is occupied
by a single gene, the Drosophila ortholog of Dystrophin. As the
det locus appeared to be highly mutable (B.R.C. and R.R.
unpublished), and thus likely to be a large gene, we tested
whether det1 failed to complement alleles of Dystrophin. The
P-element EP(3)3397 is inserted 750 bp upstream of the second
of three initiator codons that produce the ‘long’ isoforms of
Dystrophin, and it has been shown that imprecise excisions of
this element affect expression of the RNA species correspond-
ing to these protein isoforms (van der Plas et al., 2006; Fig. 2A).
Consistent with the hypothesis that det encodes Drosophila
Dystrophin, det1/EP(3)3397 transheterozygotes and EP(3)3397
hemizygotes are both 100% penetrant for the crossvein defect
characteristic of det. The crossvein phenotype produced by these
hemizygotes is more severe than that of det1 homozygotes or
hemizygotes, showing 4%, 76%, 19%, and 1% in the classes
“gapped”, “detached”, “point”, and “crossveinless”, respectively
(Fig. 2B). Notably, a shift to the most severe “crossveinless”
class is not observed in these mutants, but rather an increase in
the “detached” class, suggesting that detmay not be essential for
crossvein development per se.
To demonstrate that the crossvein defect associated with
EP(3)3397 is in fact due to the P-element insertion in Dystro-
phin, the insertion was out-crossed to a white (w) strain to show
that the crossvein defect was not genetically separable by
recombination from the w+ marker on the transposon, and this
was found to be the case. To further confirm this result, the
element was mobilized and w− revertant lines were isolated to
show that reversion of the phenotype was correlated with
precise excisions of the insertion. PCR analysis of the revertant
lines showed that all det+ revertants were associated with a
precise excision of the P-element (data not shown), confirming
that the crossvein defect is specifically associated with the P-
element insertion, which henceforth we refer to as det3397, and
consequently, that det encodes the Drosophila ortholog of
Dystrophin.
The null phenotype of detached
The variable expressivity of det1 and det3397 raised the
possibility that these mutations were partial loss-of-function
alleles and did not reveal the null phenotype of the locus in the
crossvein. The discovery of rare homozygous escapers in the
Df(3R)Exel6184 stock provided a means to characterize the
null phenotype of Dystrophin in the wing, and following simple
out-crossing, a stock was generated that produced deficiency
homozygotes at a high frequency. To verify that the deficiency
was present in these homozygotes, single-fly PCR was
performed using primers in the first major coding exon (Exon
4) and in the final coding exon (Exon 35) of the gene. While we
Fig. 3. Wing phenotypes and molecular characterization of mutations in Dy-
stroglycan. (A) Expressivity of Dg alleles DgO38, DgO43, DgO55, and DgO86 on
a per wing basis. Graphs and abbreviations are as described in Figs. 1 and 2. (B)
Diagram of the PA isoform of Dg. Upper panel shows a plot of predicted O-
linked glycosylation sites (NetOGlyc Server) in the Dg-PA isoform to highlight
the Mucin domain that binds Laminin A and other ligands. The pattern of Exons
(black boxes) and the positions of the signal sequence (purple box) and
transmembrane domain (green box) are shown above. Lower panel is a diagram
of the same isoform showing the extent of the α and β subunits of the processed
protein, and the positions of the lesions and the changes associated with the four
Dg alleles.
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included within the deficiency, we were unable to amplify
fragments for either of the Dystrophin exons (data not shown).
This result confirmed that the deficiency homozygotes
completely lack Dystrophin.
The sole morphological defect exhibited by the deficiency
homozygotes is the crossvein phenotype characteristic of det.
The phenotype of the deficiency homozygotes is essentially
identical to that of det3397 hemizygotes, showing a range of
phenotypes spanning the “gapped”, “detached” and “point”
classes, with the majority of the wings (71%) falling into the
“detached” class (Fig. 2B). Thus, our results indicate that det1
behaves as a hypomorphic allele, and det3397 as a null (at least
for the function in the crossvein) and indicate that det is not
essential for formation of the crossvein, but rather required for
the crossvein to make its connections with L4 and L5.
Drosophila Dystroglycan is required for crossvein development
Given that Dystrophin plays a role in crossvein develop-
ment, we were interested to know if other DAPC components
were also involved in the process. One of the central DAPC
components is the transmembrane glycoprotein Dystroglycan
(Ehmsen et al., 2002). In vertebrates, the nascent Dystrogly-
can peptide consists of a large glycosylated extracellular
domain, a transmembrane domain, and a short cytoplasmic
tail. The full-length protein is cleaved just N-terminal to
the transmembrane domain to yield the two mature proteins,
α-Dystroglycan and β-Dystroglycan. Mature α-Dystroglycan
has a central, highly O-glycosylated, so-called ‘Mucin
domain’ that is essential for binding to various ligands in
the extracellular matrix, that is flanked by globular N- and
C-terminal domains that are N-glycosylated. β-Dystroglycan
binds Dystrophin through a highly conserved PPXY motif that
is located at the C-terminus (Barresi and Campbell, 2006). In
Drosophila, Dystroglycan is encoded by a single gene, and at
least three different protein isoforms are produced by dif-
ferential splicing. The Drosophila protein has the same do-
main structure as its vertebrate orthologs, with Exons 1 to 7
encoding the N-terminal portion of α-Dystroglycan, Exons
8A,B, 9 and 10 encoding the Mucin domain, Exon 11 and 12
encoding the C-terminal α-Dystroglycan domain, and Exons
12 to 14 encoding β-Dystroglycan. Differential splicing of
exons 8A and B results in protein isoforms that differ in the
size of the Mucin domain (Fig. 3B; Deng et al., 2003;
Schneider et al., 2006).
Mutations affecting Drosophila Dystroglycan (Dg) have
been identified previously, and are reported to be lethal (Deng et
al., 2003), so adult phenotypes were not described. These
mutations were generated by imprecise excision of the P-
element EP(2)2241 that is inserted into the first non-coding
exon of Dg. Like det3397, the Dg2241 chromosome is lethal in
stock, but out-crossing yields homozygous viable lines that
produce a weakly penetrant crossvein defect. This defect is
similar to the “gapped” class described above, but also shows
frequent branching of the crossvein either alone or in
combination with the “gapped” phenotype (data not shown).To confirm that the crossvein defect is due to Dg, imprecise
excisions of the element were identified in a standard reversion
screen, and one of these deletions, “J43”, was used as a tester
chromosome in an F1/F2 mutagenesis for new alleles of Dg (see
Materials and methods). Four Dg mutations were isolated from
this screen that we refer to as DgO38, DgO43, DgO55, and DgO86.
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trans to the deficiency, and produce crossvein defects that fall
into the same phenotypic categories that were defined for det
(Fig. 1): all four alleles are 100% penetrant and more than 90%
of all wings show the ‘detached’ phenotype (Fig. 3A). Thus, the
expressivity of the Dg alleles is comparable to that of det3397
hemizygotes or Df(3R)Exel6184 homozygotes (cf. Fig. 2B).
Given the molecular lesions associated with these alleles (see
below) these results are also consistent with the conclusion that
the ‘detached’ phenotype is the null phenotype for the DAPC in
this function.
To confirm that these phenotypes are associated with
mutations in Dg, the alleles were characterized molecularly.
All four alleles introduce premature stop codons into the
sequence (Fig. 3B). DgO43 and DgO86 are nonsense mutations
associated with single nucleotide changes. DgO43 is associated
with a G to A substitution at position 2007 that changes W462
to a STOP, thus truncating the protein in the C-terminal
domain of α-Dystroglycan. DgO86 is associated with a C to T
substitution at position 880 in Exon 3 that changes R87 to a
STOP, thus truncating the protein within the N-terminal
domain of α-Dystroglycan. DgO55 and DgO38 are internal
deletions of the gene. DgO55 is associated with a 23 bp
deletion of the parent sequence that is replaced with a 3 bp
insertion of unrelated sequence. This deletion is contained
within Exon 11 and results in a frame shift that introduces a
termination codon three amino acids after L653. DgO38 is
associated with a 653 bp deletion that begins at position 2499
of Exon 11 and ends in the intron between Exons 11 and 12.
This introduces a termination codon three amino acids after
V625. Both of these deletions truncate the protein in the C-
terminal domain of α-Dystroglycan. These results confirm that
the EMS-induced mutations affect Dg, and given their mutant
phenotypes, that Dystroglycan, like Dystrophin, is required for
formation of the crossvein.
Viability of detached and Dystroglycan mutants
While the wing phenotypes of det and Dg alleles are
similar, mutations in the two genes have different effects on
viability. In crosses between det alleles or between det alleles
and the deficiency, the viability of the mutant class invariably
exceeds the number predicted by Mendelian ratios. Thus, in a
cross between det3397/TM6b and Df(3R)6184/TM6b, 196% of
the expected mutant class is recovered in the progeny. This
dramatic effect is largely due to the presence of the balancer
chromosomes in the cross, for when the cross is made with
det3397/Sb males, the det3397/Df and Sb/Df classes are re-
covered in a 1:1 ratio (Table 1). These data show that det
mutations do not have a significant effect on viability up to the
adult stage, and, more remarkably, that the larvae are
sufficiently robust to out-compete their heterozygous, bal-
ancer-carrying siblings. Df(3R)Exel6184 homozygotes are
recovered at a lower frequency, with 41% of the expected
class recovered in the F1 (Table 1), however, as this deficiency
is not specific for det, the lethality may be due to the loss of
other genes in the interval.In contrast to the det alleles, which are completely viable,
our EMS-induced Dg alleles are semi-viable as hemizygotes
and show 64%, 63%, 65%, and 77% viability of the expected
class for DgO38, DgO43, DgO55, and DgO86 hemizygotes,
respectively (Table 1). The mutants die predominately at the
pharate stage and many show malformation of the legs, wings,
and eyes that are occasionally observed in the viable adults (data
not shown). As pharate lethality and appendage defects are not
observed with our det alleles, the appearance of these
phenotypes suggest that Dystroglycan has earlier Dystrophin-
independent functions, perhaps in the morphogenesis of the
adult appendages during metamorphosis.
Detached and Dystroglycan affect signalling in the developing
crossveins
The involvement of the DAPC, or, at least det and Dg, in
development of the posterior crossvein raised the question of
the role these proteins play in crossvein specification, and to
what extent this function relates to characterized functions of
the DAPC in vertebrates. Crossvein specification can be divided
into three phases, which can be referred to as ‘early’, ‘middle’,
and ‘late’. In the early stage, roughly 20–22 h, after Puparium
Formation (APF), the ‘pro-crossvein’ territory is defined by the
accumulation of P-Mad in a diffuse band approximately 10–12
cells wide. At this stage, the longitudinal veins are also quite
broad, as the wing has not begun its extension after the
apposition of the two wing surfaces. In the middle stage,
between 24 and 26 h, the crossvein territory undergoes a process
of narrowing and refinement until the width of the pcv
resembles that of the longitudinal veins. In the late stage,
between 28 and 30 h, rho, dpp and Dl are expressed in
presumptive crossvein cells, the complete vein regulatory
network is operating in the crossveins, and they resemble the
longitudinal veins in all respects.
To address the role of det and Dg in these events, the
expression of the BMP ligand dpp was monitored using the
lacZ-reporter gene construct RD2 (Hursh et al., 1993).
Expression of RD2 recapitulates wild type dpp expression,
being first detectable in the longitudinal veins at about 19 h
APF, and in the crossveins about 10 h later. Expression in the
crossvein is clearly evident at 36 h APF, and this expression
persists until the adult cuticle is secreted (Figs. 4A, C). In
det3397/Df(3R)Exel6184 mutant wings, RD2 expression is
aberrant in the crossvein at the earliest stage it can be detected.
Instead of the continuous stripe of expression linking L4 and
L5, which is observed in wild type, only a small spot remains in
the intervein just anterior to L5 (Fig. 4B). This spot presumably
corresponds to the small fragment of vein that remains in det
mutant wings, and, indeed, in later stages, the expression pattern
of RD2 prefigures the “detached” phenotype that is observed in
the adult (Fig. 4D). The same phenotype is seen in Dg mutant
wings (data not shown). Two conclusions can be made from
these data. First, since dpp expression is initially detected in the
crossvein at the end of the middle stage of crossvein
development, the fact that this pattern is defective in det
mutants indicates that the DAPC acts earlier, i.e. during the
Fig. 4. DAPC mutants affect dpp expression in the crossvein. Pupal wings
stained for activity of β-galactosidase from the dpp-lacZ reporter construct
RD2. (A) Wild type pupal wing at 36 h APF. At this stage RD2 is expressed in
all longitudinal veins and crossveins. (B) det3397/Df(3R)Exel6184 pupal wing at
36 h APF. Expression of RD2-lacZ in the longitudinal veins is normal, but
expression in the crossvein is absent except for a small spot of staining just
anterior to L5 (arrow). (C) Wild type pupal wing at 70 h APF. At this stage,
expression of RD2-lacZ in the longitudinal veins is reduced, but high levels of
expression are still observed in the crossvein, and expression in the crossvein
extends the full distance between L4 and L5 (D) det3397/Df(3R)Exel6184 pupal
wings at 70 h APF. The small patch of RD2 expression anterior to L5 has
resolved into a thin line that resembles the vein proper and prefigures the
“detached” phenotype observed in the adult wing.
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and Dg are affecting dpp expression shows that DAPC function
in the wing must affect the signalling network involved in vein
specification rather than playing a merely structural role in the
vein architecture, which might be expected for the DAPC given
its molecular role as a link between the ECM and the actin
cytoskeleton in muscle.
Given the effect of DAPC components on the expression of
dpp in the pupal wing, the accumulation of P-Mad and Bs were
analysed in wild type and mutant wings to determine the effect
of DAPC mutants on early crossvein development. It has been
previously shown that the accumulation patterns of P-Mad and
Bs are reciprocal, P-Mad accumulating in the veins and Bs in
the interveins (Conley et al., 2000). This relationship extends
to the earliest phases of crossvein development. Thus, at 20–
22 h APF, when P-Mad accumulates in a broad domain, there
is a corresponding down-regulation of Bs in these cells (Figs.
5A, D). In The middle (24–26 h) and late (28–30 h) phases of
crossvein specification, the P-Mad pattern sharpens and refines
and the Bs pattern reflects this precisely (Figs. 5A–F). In det or
Dg mutant wings during the early phase of crossvein
specification, the patterns of P-Mad and Bs appear relatively
normal though in some cases it is weaker at the junction with
L4 (Fig. 5G). However, by the end of this period, P-Mad is lost
from the intervein, generally beginning with the L4 junction
and receding posteriorly, and there is a corresponding up-
regulation of Bs (Fig. 5J). In the middle stage, low levels of P-
Mad are detectable in the intervein, and the pattern of Bs
accumulation is also relatively uniform, though a slight down-
regulation can often be seen in a spot roughly midway betweenthe two longitudinal veins (Fig. 5K). By the late stage there is a
dramatic up-regulation of P-Mad accumulation in a spot of
variable size that lies between the two longitudinal veins, and a
corresponding down-regulation of Bs (Figs. 5I, L). This
recovery of the crossvein presumably reflects the augmentation
of the signalling network following the initiation of dpp, rho
and Dl expression in the pcv. These data show that, in the
pupal wing, the DAPC is required for maintenance, but not the
initiation, of the BMP signalling that initially specifies the
crossvein, and are consistent with the genetic analyses showing
that det and Dg were not essential for the formation of the
crossvein.
BMP and DAPC components affect haemocyte recruitment to
the posterior crossvein
In wild type pupal wings, numerous haemocytes are
distributed throughout the wing cavity up until the time of
the final apposition of dorsal and ventral wing surfaces at about
20 h APF. As apposition of the two wing surfaces proceeds,
these haemocytes are progressively restricted to the long-
itudinal veins, which, unlike the interveins, remain as open
channels between the two wing surfaces (Fristrom et al., 1993).
During pupal development, the haemocytes have an endogen-
ous β-galactosidase activity and can be detected by a modified
X-gal activity assay (see Materials and methods). The time at
which the haemocytes are first localized to the longitudinal
veins immediately precedes the initiation of crossvein forma-
tion, so this assay can be used to monitor the recruitment of
haemocytes to the site of the presumptive posterior crossvein.
In wild type, haemocytes are first observed in crossvein
territory just after apposition in a broad band of 20 or more
cells that is coincident with the domain of P-Mad accumulation
and the down-regulation of Bs (Fig. 6A, cf. Fig. 5). At this
stage the haemocytes are not following a channel between the
wing surfaces as they do in longitudinal veins, but rather
invading an intervein space that has connections between
dorsal and ventral surfaces. Over the course of the next 6 h, this
pattern refines until the pcv achieves its definitive form
between 26 and 30 h APF (Fig. 6B). This accumulation of
haemocytes is entirely dependent on early BMP signalling, as
it is not observed at any stage in wings homozygous for gbb4,
a hypomorphic gbb allele that is entirely crossveinless
(Wharton et al., 1999; Figs. 6C, D). Thus, the recruitment of
haemocytes to the presumptive crossvein is an early response
to BMP signalling in crossvein development.
Proper haemocyte localization also depends on det and Dg.
In the DAPC mutants, the broad accumulation of haemocytes at
20–22 h is never observed, but a small number of cells are
found in the ‘pro-crossvein’ territory, and in later stages at least
one or two cells are found trapped in the lumen of the vein
fragment that forms in these mutants (arrows in Figs. 6E–H).
Given that BMP signalling is required to recruit the haemocytes
to the pro-crossvein, the failure of haemocyte accumulation in
the DAPC mutants suggests that the DAPC is required to
maintain them in this territory, perhaps by anchoring them to
pro-crossvein cells. This model accounts for the failure to
Fig. 5. Effects of det and Dg on BMP signalling in crossvein specification. Confocal images of pupal wings immunostained for the P-Mad and Blistered (Bs) proteins.
(A–C) Accumulation of P-Mad in pupal wings in the early (A), middle (B) and late (C) phases of crossvein specification. In the early phase, P-Mad expression is broad
and the boundaries are diffuse. In the middle phase the expression refines and sharpens, and by the late phase, the crossvein is completely established. (D–F)
Expression of Bs in pupal wings in the early (D), middle (E), and late (F) phases of crossvein specification. The pattern of Bs expression is reciprocal to that of P-Mad,
and shows the same progression of sharpening and refinement. (G–I) Accumulation of P-Mad in det3397/Df(3R)Exel6184 mutant wings. P-Mad is initially broad as in
wild type, but is rapidly lost, generally from the anterior to the posterior (G). In middle stages, the expression of P-Mad is low throughout the crossvein region (H), and
in late stages, a strong spot of P-Mad expression appears in the intervein between L4 and L5. The P-Mad accumulation in this vein is more intense than in the
longitudinal veins. (J–L) Expression of Bs in det3397/Df(3R)Exel6184 mutant wings. As in wild type, the Bs pattern is reciprocal to that of P-Mad.
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initially, due to their inability to be anchored there, and also the
small number of cells that invariably remain, as they would be
continuously recruited to the region of highest BMP signalling
until eventually becoming trapped in the vein lumen.
Genetic interactions between detached and signalling
pathways in the developing wing
Our genetic analysis of det and Dg mutants showed that the
crossvein defects produced by these mutations were variable
(see Figs. 2 and 3), and were also sensitive to genetic
background and responsive to selection (B.R.C. and R.P.R.,
unpublished). Given that det and Dg affect maintenance of
BMP signalling in early crossvein development, we tested for
dominant interactions between det mutants and components ofthe BMP pathway. Specifically, we looked for enhancement of
the weak det1/Df(3R)Exel6184 crossvein defect in backgrounds
lacking one copy of the various BMP signalling components.
Surprisingly, none of the components tested, including dpp
(shortvein and disk alleles), gbb, tkv, Mad or Med, showed any
significant enhancement of the det mutant phenotype. In dpps;
det double mutant combinations, the phenotypes of the two
mutations are additive with neither the dpps defect in the
longitudinal veins nor the det defect in the crossveins showing
any significant enhancement. Similarly, no interaction was
observed between det and either Dg or the potential DAPC
ligand Laminin A (data not shown).
In contrast to the results obtained from interactions with
BMP and DAPC components, we observed a striking
suppression of the det mutant phenotype by Delta (Dl). This
interaction is seen in flies heterozygous for det3397 in trans
Fig. 6. Localization of haemocytes to the presumptive posterior crossvein in
wild type and mutant wings. Bright field images of pupal wings stained for
endogenous β-galactosidase activity, which identifies the haemocytes that
move between the two wing surfaces. (A, B) Haemocyte localization in wild
type pupal wings at 22 h (A) and 26 h (B) APF. At 22 h, haemocytes are
localized to the presumptive pcv, and the width of the stripe reflects the extent
of P-Mad expression that is observed at this stage of development (see Fig.
5A). By 26 h, the pattern has refined and the haemocytes are “trapped” in the
lumen of the vein. (C, D) Haemocytes do not localize to the pcv region in
pupal wings homozygous for gbb4, a hypomorphic allele that is semi-viable
and completely lacks the pcv. (E, F) In det mutants, the number of haemocytes
is either greatly reduced or completely absent. Often only one or two
haemocytes are present in the region (arrows) and vein fragments detected in
26 h det mutant wings always have at least one haemocyte trapped in the
lumen. (G, H) In Dg mutants, the number of haemocytes is also either greatly
reduced or they are absent at both time points. (I, J) In wings heterozygous for
a null allele of Delta, the accumulation of haemocytes, both early and late, is
normal, though, at 26 h, the skewing of the pcv that is observed in the adult
wing is apparent (cf. Fig. 7F). (K, L) In Df(3R)ED5492/Df(3R)Exel6184
mutant wings, haemocytes are not maintained in the pro-crossvein as in the det
mutant wing (E), however, later in development, when the connections are
made to the longitudinal veins, the crossvein is repopulated with haemocytes
moving in from L4 and L5.
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Df(3R)ED5942. The former deficiency uncovers det, and the
latter uncovers det and Dl, which lies ∼100 kb proximal (see
Fig. 2A). Due to the haploinsufficiency of Dl, the deficiencies
show different phenotypes as heterozygotes: Df(3R)Exel6184
heterozygotes are wild type, while Df(3R)ED5942 heterozy-
gotes have thickened longitudinal veins and terminal deltas that
are the hallmarks of Dl haploinsufficiency (Figs. 7A, B; Vassin
and Campos-Ortega, 1987). In trans to det3397, Df(3R)Exel6184
shows the detmutant phenotype with the majority of crossveins
failing in the ‘detached’ class (Fig. 7C), while Df(3R)ED5942
shows a phenotype that is indistinguishable from the Dl haplo-
insufficient phenotype: the crossveins in these wings extend the
full distance between L4 and L5, or, in rare cases, have a small
gap at the junction with L4 (Fig. 7D). Indeed the same
suppression is observed in Df(3R)ED5492/Df(3R)Exel6184
transheterozygotes that completely lack the Dystrophin gene
(Fig. 7E). To demonstrate that this suppression was due to
Delta and not another gene uncovered by Df(3R)ED5942,
we tested if an amorphic Delta allele, Dl9P, could suppress
the Dg crossvein defect. As observed with det, DgO86 homo-
zygotes carrying one copy of Dl9P show a suppression of the
‘detached’ phenotype (Figs. 6G, H). Similar, albeit weaker,
suppression of both det andDg is observed in flies heterozygous
for a null allele of Notch (data not shown). Thus, reducing the
level of Notch signalling suppresses the det mutant phenotype,
suggesting that the effect of the DAPC on BMP signalling may
be indirect, i.e. by antagonising the Notch signalling that
normally antagonizes BMP signalling (see Discussion).
The suppression of det and Dg crossvein phenotypes by
Delta haploinsufficiency raises the question of whether this
effect is downstream or upstream of the activation of the DAPC
and recruitment of the haemocytes in the pro-crossvein
territory. To address this question, the accumulation of
haemocytes was monitored in Delta heterozygotes and det
mutants heterozygous for Delta. In Dl9P heterozygotes, the
recruitment, maintenance and refinement of haemocytes to
the pro-crossvein are normal (Figs. 7I, J). Thus, despite the
fact that the crossvein is broader in the mutant, this change
in morphology is not associated with an increase in the num-
ber of haemocytes or in their refinement. In Df(3R)ED5492/
Df(3R)Exel6184 transheterozygotes, the vein phenotype re-
sembles the Delta heterozygote (Fig. 7E), but the haemocyte
phenotype resembles the det mutant, with only a few
haemocytes remaining in the pro-crossvein territory (Fig. 6K,
cf. Fig. 6E). Later in development, the haemocytes repopulate
the crossvein, when the connections with L4 and L5 allow
migration of the haemocytes from the longitudinal veins (Fig.
6L). These results show that the Delta haploinsufficient
phenotype is entirely epistatic to the DAPC mutant phenotype,
and thus downstream of DAPC function and haemocyte
accumulation. Thus, lowering the activity of the Notch pathway,
obviates the need for either the DAPC or haemocyte accumula-
tion, and allows BMP signalling to promote crossvein develop-
ment independent of these functions. These results are
consistent with the hypothesis that DAPC function, and perhaps
haemocyte accumulation are required for the normal down-
Fig. 7. Interactions between det and Delta. Adult wings showing the effect
of Delta on expression of the det crossvein defect. (A) A heterozygote of
Df(3R)Exel6184, which removes det but not Delta, shows the wild type vein
pattern. (B) A heterozygote of Df(3R)ED5942, which removes both det and
Delta, shows the haploinsufficient Dl phenotype consisting of vein thickening,
particularly along L2, L5 and the pcv. (C) Wing from a det3397/Df(3R)Exel6184
transheterozygote showing the “detached” phenotype, which is the most common
phenotypic class produced by this genotype (see Fig. 2B). (D)Wing from a det3397/
Df(3R)ED5942 transheterozygote which is both mutant for det and haploinsuffi-
cient for Delta. In this combination, the crossvein defect is suppressed and the
vein thickening resembles that of the deficiency heterozygote. (E) Wing from a
Df(3R)ED5492/Df(3R)Exel6184 transheterozygote show suppression of the det
phenotype by Delta even in a wing that completely lacks det function. (F) A
Dl9P heterozygote, showing that the haploinsufficient phenotype produced by
this allele is the same as that produced by Df(3R)ED5942 heterozygotes. (G)
Wing from a DgO86 homozygote showing the characteristic ‘detached’
phenotype. (H) Wing from a DgO86/DgO86; Dl9P/+ fly. The detached phenotype
is suppressed and the wing shows only the Delta haploinsufficient phenotype.
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which in turn leads to an up-regulation of the BMP pathway.
Discussion
An atypical function for the Drosophila DAPC in vein
development
In this report, we show that the ‘crossveinless’ gene de-
tached encodes the Drosophila ortholog of Dystrophin.Analysis of our mutant alleles shows that Dystrophin mutants,
even complete nulls, are viable and fertile and exhibit only one
overt morphological defect: a variable loss of the posterior
crossvein in the wing. The same phenotype is also produced by
null mutations in Dystroglycan, demonstrating that both of the
core elements of the DAPC are involved in crossvein
specification in Drosophila, and suggesting that a link between
extracellular matrix and Actin cystoskeleton, which is the
canonical molecular function of the DAPC (Ervasti and
Campbell, 1993), is involved in crossvein development.
The discovery that the Drosophila DAPC plays a role in vein
development is striking as it is the first instance where the
DAPC has been implicated in a developmental process that
bears no obvious relationship to the DAPC functions ascribed to
the complex in mammals. In the mouse, knock-outs of DAPC
components lead to muscular dystrophy, defects in the post-
synaptic membrane of the neuromuscular junction (NMJ),
central nervous system and retinal abnormalities, reduced
nNOS levels in the sarcolemma, and, for Dystroglycan, defects
in embryonic basement membrane assembly (reviewed in Blake
et al., 2002). In zebrafish, the Dystroglycan mutant results in
detachment of somitic muscles during embryogenesis (Parsons
et al., 2002). In the invertebrates, mutations in the Caenor-
habditis elegans Dystrophin ortholog result in a decrease in
acetylcholinesterase activity at the NMJ, but have no effect on
muscle integrity (Bessou et al., 1998; Giugia et al., 1999), and in
Drosophila, defects associated with the neuromuscular junc-
tion, neuronal migration, muscle integrity, and epithelial
polarity have been described based on analyses of classical
mutants and RNAi knock-downs (Schneider et al., 2006;
Shcherbata et al., 2007; van der Plas et al., 2007). Despite this
wide range of mutant studies in a variety of model systems, the
DAPC has not previously been implicated in more general
developmental processes. Yet, in flies, the DAPC clearly plays a
role in vein specification, a process that has no relation to either
muscles or neurons, and this raises the question of whether this
function is specific to Drosophila or represents a more general
function for the DAPC in insects and in other phyla.
A second important point about the results in this report is that
they are not entirely in agreement with the previously published
work on Drosophila Dystrophin and Dystroglycan. As men-
tioned above, previous studies identified two Dystroglycan
alleles Dg248 and Dg323 which were isolated by imprecise
excision of the P-element insertion EP(2)2241 (Deng et al.,
2003). These mutations were reported to be lethal, and mutant
clones in ovarian germline and follicle cells give rise to defects in
oocyte and epithelial polarity, respectively. These results have
been confirmed in other reports using the same alleles
(Schneider et al., 2006). By contrast, the alleles reported here
are at least semi-viable, both as homozygotes and hemizygotes,
and show no evidence of the polarity defects that have been
reported for the other alleles (this report and unpublished). These
differences may be accounted for, at some level, in light of the
different types of lesions associated with the alleles. The two
alleles described previously are small deletions affecting the first
non-coding exon of Dg and adjacent cis-regulatory sequences,
whereas the alleles reported here are all located within the Dg
530 C.P. Christoforou et al. / Developmental Biology 313 (2008) 519–532coding region. Given that our alleles are molecular nulls, it is
possible that the more severe phenotypes associated with Dg248
and Dg323 are in fact due to these deletions affecting either
adjacent or nearby genes or their cis-regulatory sequences.
Further work will need to be done to verify this possibility.
In the case of Dystrophin, two independent reports using
RNAi to knock-down the function of all protein isoforms have
claimed that loss of Dystrophin results in either lethality or age-
dependent muscle degeneration (Shcherbata et al., 2007; van
der Plas et al., 2007). It is noteworthy that these two studies are
not entirely in agreement with one another. Shcherbata et al.
(2007) claim that Dg-RNAi or Dys-RNAi, when expressed
ubiquitously with Tubulin-Gal4 or in muscles with 24B-Gal4,
are adult viable, and the animals exhibit mobility defects and
chronic muscle degeneration. van der Plas et al. (2007), on the
other hand, claim that Dys-RNAi driven by 24B-Gal4 is
predominantly pharate lethal with a few escapers that die shortly
after eclosion. The results presented here lie between these two
extremes. Df(3R)Exel6184 homozygotes are semi-viable (Table
1), and the majority of animals that do not survive are pharate
lethal. The surviving flies have a somewhat shorter lifespan than
other genotypes tested, but easily survive to 40 days after
eclosion, and show no evidence of mobility defects or muscle
degeneration (unpublished). With regard to the lethality, the
differences observed in these studies could be a consequence of
the different genetic backgrounds and insertions that were used.
It is more difficult to account for the differences observed in the
muscle degeneration phenotype. One possibility is that the
experiments reported here were performed at the normal
temperature of 25 °C whereas the RNAi experiments of van
der Plas et al. (2007), at least, were all done at 29 °C. It is
possible that the elevated temperature exacerbates the degen-
eration phenotype leading to the reported results. Again, further
experiments will need to be done to resolve these differences.
A role for the DAPC in the vein signalling network
Since DAPC mutations in mammals give rise to muscular
dystrophies, the primary role assigned to the complex has been aFig. 8. Mechanisms of vein specification in longitudinal veins and crossveins. (A)
Illustration of the basic vein regulatory network involving the BMP, EGFR and
Notch pathways. Throughout the figure, components of the BMP, EGFR, andNotch
pathways are shown in red, blue and green, respectively. Top panel shows expression
patterns of several components of these pathways with respect to the vein, pro-vein,
and intervein domains shown below.Details on the regulatory network are described
in the text (see Introduction). (B) Signalling events in early (top) and late (bottom)
phases of crossvein specification. In the early phase, Gbb-dependent BMP signalling
defines what is referred to here as a ‘pro-crossvein’ territory that overlays pro-vein
and intervein territories between L4 and L5. This signalling has two known
consequences, the down-regulation of Bs in the pro-crossvein, and the recruitment of
haemocytes into the extracellular space between dorsal and ventral wing epithelia. In
addition, the signalling leads to activation of the DAPC (det and Dg), which are
necessary for maintenance of the BMP signal, and thus must feed back on to the
BMP pathway and augment it. One possible mechanism for this is that the activated
DAPC down-regulates Notch signalling (which antagonizes BMP signalling) in the
pro-vein territories. This opens the barrier between vein and presumptive crossvein
and allows BMP ligands in the longitudinal veins to diffuse into the crossvein region
and amplify the Gbb-dependent BMP signal. Ultimately, the entire regulatory
network shown in (A) is recapitulated in the crossvein.structural one: to maintain the integrity of the sarcolemma by
forming a bridge between the ECM and the Actin cytoskeleton
(Ervasti and Campbell, 1993). In the developing crossvein,
whatever the mechanism of action, the point of DAPC function
appears to be to affect the activity of signalling pathways that
govern crossvein specification, and thus, the function is not
merely structural. Our data suggest a mechanism whereby the
DAPC augments BMP signalling in the pro-crossvein territory
by down-regulating the activity of the Notch pathway in the
pro-vein territory flanking L4 and L5 at the junction with the
prospective crossvein (Fig. 8). This down-regulation would
531C.P. Christoforou et al. / Developmental Biology 313 (2008) 519–532allow diffusion of BMP ligands from the longitudinal veins into
the crossvein territory and thus, indirectly augment BMP
signalling in the crossvein.
This model can be reasoned as follows. As P-Mad
accumulation in the crossvein territory precedes DAPC
function, the DAPC-dependent augmentation is presumably a
consequence of the initial BMP signalling event. This would
place the BMP and DAPC pathways as two sequential elements
in a feedback loop: the initial BMP signal activates the DAPC
which then signals back, either directly or indirectly, to augment
the activity of BMP signalling. As both Dystrophin and
Dystroglycan appear to be expressed uniformly throughout
the pupal wing (C.P.C. and R.P.R., unpublished), these DAPC
components are presumably activated by BMP signalling rather
than being transcriptional targets of the pathway.
One of the consequences of DAPC activation is the
anchoring of haemocytes in the pro-crossvein territory. It is
clear that BMP signalling is sufficient to recruit haemocytes to
the region, as evidenced by the persistent haemocytes
observed in det and Dg mutant wings, but BMP signalling
alone is not able to anchor them there, which accounts for the
lack of haemocyte accumulation in the pro-crossvein in det
and Dg mutants despite the relatively normal early accumula-
tion of P-Mad. The persistence of haemocytes in the vein
fragment that eventually arises simply reflects the continued
recruitment of haemocytes to the site of highest BMP
signalling, which, in the mutant wings, is half way between
the two longitudinal veins. Whether the haemocytes them-
selves are essential for normal vein development cannot be
determined at present, but the presence of a complete
crossvein in Df(3R)ED5492/Df(3R)Exel6184 wings indicates
that in wings with compromised Notch signalling, neither the
DAPC nor the accumulation of haemocytes is necessary for
crossvein formation.
While the defects in P-Mad accumulation that are observed
in det and Dg mutant wings indicate that the ultimate effect of
DAPC function in the wing is augmentation of BMP signalling,
the results of genetic interaction studies suggest that this effect
may be indirect. A direct effect on BMP signalling is not
consistent with the failure to recover interactions between BMP
components and det or Dg. While, in principle, this negative
result does not rule out the possibility that the two pathways
intersect (as they may be sufficiently robust so as not to show
interactions under the conditions we are able to create), it is
unexpected given the striking sensitivity of det and Dg
mutations to genetic background. This sensitivity suggests
that the DAPC phenotypes are on or near a threshold that
would be susceptible to enhancement. A possible explanation
for this result can be found in the dramatic suppression of the
det phenotype by Delta. Taking into account this result, it is
possible that the effect of the DAPC on BMP signalling may be
indirect, resulting from an effect on Notch signalling. Thus, the
initial BMP signal may activate the DAPC, but the DAPC
feeds back on BMP signalling by down-regulating the activity
of the Notch pathway in the pro-vein regions. In this case, the
DAPC augments BMP signalling by down-regulating a BMP
antagonist.It has previously been suggested that the source of BMP
signalling that gives rise to the early broad accumulation of
P-Mad in the crossvein territory is dependent on the diffusion of
Dpp:Gbb heterodimers from the longitudinal veins (O'Connor
et al., 2006). This model, while accounting for some of the
phenotypes produced by somatic clones of BMP pathway
components (Ralston and Blair, 2005; Ray and Wharton, 2001),
does not account for how these heterodimers are able to
overcome the repression of BMP diffusion that is due to up-
regulation of tkv by Notch signalling in the pro-vein territory.
The proposal that the DAPC may function as a link between the
initial Gbb-dependent BMP signal and the down-regulation of
Notch signalling in the pro-veins would reconcile this problem.
In this scenario, the initial BMP signal activates the DAPC in
the crossvein territory. The DAPC then down-regulates Notch
signalling which opens the vein regions of L4 and L5 to the
intervein allowing the diffusion of BMP ligands into the
presumptive crossvein territory (Fig. 8B). An interesting
corollary of this model is that, since a vein fragment forms in
DAPC mutant wings, the specification of the crossvein in the
intervein territory does not require either the DAPC or diffusion
of BMP ligands from the longitudinal veins. Moreover, as the
resulting crossvein fragment is of normal thickness and
morphology, refinement and sharpening are also independent
of the diffusion of BMP heterodimers from the longitudinal
veins.
Given this model, it remains to be determined first, how the
initial Gbb-dependent BMP signalling activates the DAPC, and
second, how the DAPC exerts its effect on Notch signalling.
With regard to the first point, it is possible that the BMP signal
affects DAPC function via Rho. There is precedent for a direct
effect of TGF-β signalling on Rho leading to reorganization of
the Actin cytoskeleton (Ozdamar et al., 2005), and this type of
mechanism is consistent with the involvement of cv-c, a Rho-
GAP, in vein development (Denholm et al., 2005). With regard
to the second point, the effect of the DAPC on Notch signalling
could occur directly with a DAPC-dependent reorganization of
the basal plasma membrane of pro-vein cells that interferes with
cell signalling events at the plasma membrane. Alternatively,
the effect could be due to overriding the antagonistic effect of
Notch activity by creating an extracellular environment that
allows BMP diffusion from the longitudinal veins independent
of Notch activity. Further research will be required to determine
the precise mechanisms involved in this process.
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